Shui Wang (S Wang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Locally Advanced

Circulating Tumor

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Cancer medicine

Cancer management and research

NPJ breast cancer

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Zhimin Shao, Zhongsheng Tong, Qiang Liu, Wei Li, Li Cai, Kunwei Shen, Huiping Li, Chuan Wang, Jin Yang, Zhenchuan Song, Shui Wang, Ting Luo, Wenhe Zhao, Haibo Wang, Yueyin Pan, Jianyun Nie, Xiaohua Zeng, Yanqing Bai, Wendy Chiang, Valeria Guarnaccia, Yu Bi, Binghe Xu
Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer medicine 13 (15) (2024)
Ge Ma, Jingyi Wang, Jingyue Fu, Rui Chen, Mengdi Liang, Minghui Li, Tiansong Xia, Xiaoan Liu, Shui Wang
Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer. Breast cancer research and treatment (2023)
Qiannan Zhu, Jue Wang, Yuenian Shi, Xiaoming Zha, Shui Wang
Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer. Cancer management and research 14 (2022)
Hong Pan, Kai Zhang, Ming Wang, Lijun Ling, Shui Wang, Wenbin Zhou
The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population-based observational study. Cancer (2021)
Jingyi Wang, Ge Ma, Han Ge, Xu Han, Xinrui Mao, Xinyang Wang, Jordee Selvamanee Veeramootoo, Tiansong Xia, Xiaoan Liu, Shui Wang
Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer. NPJ breast cancer 7 (1) (2021)
Ge Ma, Yi Jiang, Mengdi Liang, JiaYing Li, Jingyi Wang, Xinrui Mao, Jordee Selvamanee Veeramootoo, Tiansong Xia, Xiaoan Liu, Shui Wang
Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer. Therapeutic advances in medical oncology 12 (2020)
Ge Ma, Jingyi Wang, Huaxing Huang, Xu Han, Jin Xu, Jordee Selvamanee Veeramootoo, Tiansong Xia, Shui Wang
Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer. Cancer medicine 9 (7) (2020)
J Wang, G Ma, X Han, M Liang, X Wang, T Xia, Shui Wang
The low expression of miR-1976 in plasma samples indicating its biological functions in the progression of breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (11) (2020)
Minghui Li, Xuan Zou, Tiansong Xia, Tongshan Wang, Ping Liu, Xin Zhou, Shui Wang, Wei Zhu
A five-miRNA panel in plasma was identified for breast cancer diagnosis. Cancer medicine 8 (16) (2019)